Needham & Company
-
Achaogen (AKAO) PT Raised to $29 at Needham & Company Following R&D Day
-
Unusual 11 Mid-Day Movers 12/13: (USEG) (GLF) (AKAO) Higher; (PRTO) (INOV) (LIFE) Lower (more...)
-
Pre-Open Stock Movers 12/13: (NVCN) (AKAO) (SCYX) Higher; (PRTO) (INOV) (BDSI) Lower (more...)
-
Achaogen (AKAO) Bucks Stock Offering Weakness Amid Bullish Analyst Predictions
-
After-Hours Stock Movers 12/12: (ABUS) (URBN) (BA) Higher; (INOV) (AKAO) (PAY) Lower (more...)
-
Needham & Company Upgrades Achaogen (AKAO) to Buy
-
Notable Analyst Rating Changes 6/14: (AKAO) (VG) (ALGT) Upgraded; (LFL) (CDNS) (MRNS) Downgraded
-
Achaogen to Present at the 15th Annual Needham Health Care Conference
-
Needham & Company Downgrades Achaogen (AKAO) to Hold
-
Achaogen to Present at 14th Annual Needham Healthcare Conference
-
Achaogen to Present at 14th Annual Needham Healthcare Conference
-
Achaogen (AKAO) PT Lowered to $15 at Needham & Company; 'Buy' Maintaned
-
Achaogen Announces Fourth Quarter and Full Year 2014 Results
-
Achaogen Announces Fourth Quarter and Full Year 2014 Results
-
Needham & Company Starts Achaogen (AKAO) at Buy
-
Achaogen (AKAO) Open, Trends Higher

